FindTrial
Sign In

A randomized controlled parallel trial of clinical pharmacists using the mode of ''medication management (MTM) combined with patient self-management (SMS)'' for secondary prevention of ischemic stroke intervention

A randomized controlled parallel trial of clinical pharmacists using the mode of ''medication management (MTM) combined with patient self-management (SMS)'' for secondary prevention of ischemic stroke intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047677
Enrollment
Unknown
Registered
2021-06-21
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

experimental group:Pharmacist-led "Drug Treatment Management (MTM) combined with Patient/Family Management (SMS)" disease management model
control group:Daily mission intervention

Sponsors

Gansu Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with ischemic stroke who initiate secondary prevention; 2. combining more than 1 kind of chronic disease or complications; 3. The number of conventional drugs >= 3 ; 4. Poor drug compliance.

Exclusion criteria

Exclusion criteria: 1. Cognitive dysfunction; 2. combining several systems of serious diseases; 3. Tumor patients; 4. Unable to cooperate with the completion of telephone follow-up and written records.

Design outcomes

Primary

MeasureTime frame
Re-admission rate;—

Secondary

MeasureTime frame
Incidence of adverse reactions;Drug compliance;Quality of life;Blood pressure;Blood glucose;Pharmacist costs;—

Countries

China

Contacts

Public ContactBao Yun

Gansu Provincial Hospital

baoyun2009@126.com+86 18119411206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026